EGFR and non-small cell lung carcinoma: Additionally, it was also found that a relatively lower dose of curcumin also sensitized erlotinib-resistant NSCLC cells to erlotinib’s cytotoxic effects, reduced expressions of EGFR and also inhibited NF-κB activation (Li et al., 2013).